Skip to main content
HR 5952 102th Congress House Health Administrative fees Appropriations Collection of accounts Congressional reporting requirements Department of Health and Human Services Drug industry Drugs Federal employees Indexing (Economic policy) Licenses Pharmaceutical research Salaries User charges Veterinary medicine

Prescription Drug User Fee Act of 1992

Introduced: September 16, 1992 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 13 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 24, 1992
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 702. Pursuant to the order of September 22, 1992.
Sep 22, 1992
Motion to reconsider laid on the table Agreed to without objection.
Sep 22, 1992
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Sep 22, 1992
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Sep 22, 1992
DEBATE - The House proceeded with forty minutes of debate.
Sep 22, 1992
Considered under suspension of the rules.
Sep 22, 1992
Mr. Waxman moved to suspend the rules and pass the bill, as amended.
Sep 22, 1992
Placed on the Union Calendar, Calendar No. 512.
Sep 22, 1992
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 102-895.
Sep 17, 1992
Committee Consideration and Mark-up Session Held.
Sep 17, 1992
Ordered to be Reported (Amended) by Voice Vote.
Sep 16, 1992
Referred to the House Committee on Energy and Commerce.
Sep 16, 1992
Introduced in House
 Plain-English summary Congressional Research Service

Prescription Drug User Fee Act of 1992 - Amends the Federal Food, Drug, and Cosmetic Act to provide authority for the Secretary of Health and Human Services to assess and collect fees from manufacturers of prescription drugs beginning in FY 1993. Establishes a schedule for prescription drug application and supplement fees, prescription drug establishment fees, and prescription drug product fees. Provides for the annual adjustment of such fees to reflect increases in the Consumer Price Index for urban consumers or increases in Federal pay. Authorizes the Secretary to waive or reduce fees.

Prohibits the assessment of fees for a fiscal year after FY 1993 unless appropriations for salaries and expenses of the Food and Drug Administration (FDA) are equal or greater than such appropriations for FY 1992. Credits such fees to the appropriation account for salaries and expenses of the FDA. Authorizes appropriations for FY 1993 through 1997.

Provides a mechanism for collecting unpaid fees.

Requires the FDA to make annual reports to the Congress on this Act.

What's happening now September 24, 1992

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 702. Pursuant to the order of September 22, 1992.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1